Quantcast

Latest Steroids Stories

2014-09-16 23:10:26

New Line Medical has made bulky, confusing cholesterol screening supplies a thing of the past thanks to its new product: New Line Medical Universal Cholesterol Screening Kits. Lafayette, Louisiana (PRWEB) September 16, 2014 New Line Medical is proud to announce the launch of an amazing new product for corporate wellness programs and wellness events: the New Line Medical Universal Cholesterol Screening Kit. “In the past, cholesterol screening was a big hassle for wellness events because...

2014-09-15 12:27:24

Expert Panel Re-affirms the Importance of Setting Cholesterol Goals for the Prevention of Heart Attack and Stroke NEW YORK, Sept. 15, 2014 /PRNewswire/ -- Today, the National Lipid Association (NLA) released new recommendations based on a panel of independent experts, published in the Journal of Clinical Lipidology. The recommendations highlight the importance of doctors and patients setting cholesterol goals and focusing on patient's risk and risk factors, rather than on specific...

2014-09-10 23:11:45

According to the Center for Disease Control and Prevention, approximately one in every six Americans has high cholesterol. New York Times and USA Today Best Selling author, Sanjay Jain, M.D. MBA explains how to identify signs of high cholesterol and reduce cholesterol levels without the use of expensive medications. Washington, DC (PRWEB) September 10, 2014 Recent statistics from the Center for Disease Control and Prevention show that 17% of Americans--one out of every six adults--have...

2014-09-08 23:01:21

Free Mount Sinai Health System Cholesterol Fairs in September to Raise Awareness About the Importance of Maintaining Healthy Cholesterol Levels New York, NY (PRWEB) September 08, 2014 This September the Mount Sinai Health System will host five, free cholesterol fairs in honor of National Cholesterol Education Month. The effort is meant to increase awareness about the importance of maintaining healthy cholesterol levels to prevent cardiovascular diseases and stroke, and to promote a daily...

heart attack protein
2014-09-04 03:00:00

Vincent Lamontagne, University of Ottawa Heart Institute A team of researchers at the University of Ottawa Heart Institute, led by Dr. Alexandre Stewart, have uncovered an intriguing link between heart attacks and a protein that is of great interest to drug companies for its impact on cholesterol. The team found that levels of the protein PCSK9 were elevated in the blood of patients having an acute heart attack, but not in those who never had a heart attack or who had recovered from one...

2014-09-03 12:29:54

NEW YORK, Sept. 3, 2014 /PRNewswire/ -- S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on Matinas BioPharma Holdings, Inc. Matinas BioPharma Holdings, Inc. (MTNB), in the development stage as of September 2(nd), 2014, is a biopharmaceutical company focusing on identifying and developing novel pharmaceutical products for the treatment of abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular and...

2014-09-02 08:30:18

TEL-AVIV, Israel, Sept. 2, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, announced today that it successfully completed two six-month chronic toxicology studies of its drug candidate, aramchol. These studies were performed in compliance with the European Medicines Agency's...

2014-09-02 08:29:42

Represents First Marketing Authorization Application in the European Union for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Sept. 2, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for evolocumab seeking approval for the treatment of high cholesterol. Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase...

Fenofibrate for diabetic women
2014-08-21 03:00:45

Dan Gafney, University of Sydney The cholesterol-lowering drug fenofibrate cuts cardiovascular disease risks by 30 percent in women with type-2 diabetes, a new University of Sydney study reveals. "The finding is good news for women," says the study's chairman, University of Sydney Professor, Tony Keech. "The study shows that fenofibrate reduced the risk of dying from cardiovascular disease, or having a stroke or other adverse cardiovascular event by 30 percent in women and 13 percent...

2014-08-20 23:03:06

The research organization offers tips on how to help lower cholesterol. San Antonio, TX (PRWEB) August 20, 2014 Texas Medical Research Associates is looking for candidates to participate in their new study. The study will help test the effectiveness of a new drug looking to help lower cholesterol. People who suffer from high cholesterol may be eligible to participate in the study. According to the American Heart Association, too much cholesterol in the blood can lead to cardiovascular...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related